海外の治験の状況「前立腺癌」での検索結果
118件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- PARALLEL GROUP SINGLE BLIND STUDY TO COMPARE THE PHARMACOKINETIC PROFILES AND PHARMACODYNAMIC RESPONSE OF A NEW DEPOT FORMULATION OF GOSERELIN ACETATE CAPSULE/IMPLANT FOR SUBCUTANEOUS INJECTION, PEPTI 10.8 MG, TO ZOLADEX 10.8 MG CAPSULE/IMPLANT IN AMBULATORY PATIENTS WITH ADVANCED CARCINOMA OF THE PROSTATE.
- -C61 Malignant neoplasm of prostate Malignant neoplasm of prostate;C61 ;Malignant neoplasm of prostate
- Canada, Chile, Colombia, Peru, Serbia, Ukraine
- 2019-06-17
Not Recruiting
- Initial prostate biopsy: 12 versus 20 cores - prospective study
- Malignant neoplasm of prostate C61;C00-D48
- Brazil
- 2018-01-29
Not recruiting
- Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer
- Bone Metastases in Men With Hormone-Refractory Prostate Cancer;Bone Metastases in Subjects With Advanced Breast Cancer;Bone Metastases in Men With Hormone-Refractory Prostate Cancer;Bone Metastases in Subjects With Advanced Breast Cancer
- Argentina, Austria, Belgium, Brazil, Czech Republic, Czechia, France, Hungary, India, Israel, Italy, Japan, Latvia, Lithuania, Panama, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
- 2011-08-04
Not Recruiting
- Clinical trial to evaluate the efficacy of drug product Denosumab in patients with advance cancer.
- Bone Metastases in Men With Hormone-Refractory Prostate Cancer Bone Metastases in Subjects With Advanced Breast Cancer
- Argentina, Australia, Brazil, Chile, India, Israel, Panama, Peru, Russian Federation, South Africa, Ukraine, United Kingdom
- 2012-10-11
Not Recruiting
- Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen
- Mestatic Hormone Refractory Prostate Cancer
- Argentina, Australia, Austria, Belgium, Canada, Croatia, Czech Republic, Finland, France, Hungary, India, Iran (Islamic Republic of), Israel, Italy, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, United Kingdom
- 2011-06-15
Not Recruiting
- Open-Label Access Protocol of Denosumab for Subjects with Advanced Cancer
- Bone Metastases in Subjects with Advanced Breast Cancer and Bone Metastases in Men with Hormone-Refractory Prostate Cancer MedDRA version: 16.0 Level: LLT Classification code 10027475 Term: Metastatic breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 16.0 Level: LLT Classification code 10005993 Term: Bone metastases System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 16.0 Level: PT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Belgium, Brazil, Chile, Czech Republic, European Union, France, Hungary, India, Israel, Italy, Japan, Latvia, Lithuania, Panama, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
- 2011-08-10
Not recruiting
- A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
- Benign Prostatic Hyperplasia;Enlarged Prostate;Benign Prostatic Hyperplasia;Enlarged Prostate;Benign Prostatic Hyperplasia;Enlarged Prostate;Benign Prostatic Hyperplasia;Enlarged Prostate
- Argentina, Belgium, Brazil, Canada, France, Germany, Greece, Italy, Mexico, Poland, Russian Federation, Turkey, United States
- 2010-06-01
Not Recruiting
- 01 July
- Hormone refractory prostate cancer with skeletal metastases MedDRA version: 14.1 Level: PT Classification code 10027452 Term: Metastases to bone System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Brazil, Canada, Czech Republic, France, Germany, Hong Kong, Israel, Italy, Netherlands, Norway, Poland, Singapore, Slovakia, Spain, Sweden, United Kingdom, United States
- 2008-02-25
